1372514 - Eyegate Pharmaceuticals Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - EYEG (1372514)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
23 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P1+13+7+15+64
S6-2-2-20-46

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

M
2017-09-14
EYEGWirostko BarbaraChief Medical OfficerA - Grant$1.22+19,200278,742+7%+$23,334
2017-08-15
EYEGRomano SarahInterim CFOP - Purchase$1.00+10,00032,500+44%+$10,000
2017-08-10
EYEGFrom StephenPres, CEOP - Purchase$1.03+12,500272,465+5%+$12,875
D
2017-06-14
EYEGRomano SarahInterim CFOP - Purchase$0.00+20,00022,500+800%+$0
D
2017-06-14
EYEGFrom StephenPres, CEOP - Purchase$0.00+60,000259,965+30%+$0
D
2017-06-02
EYEGChaney Paul GDirM - OptEx$0.65+17,57041,229+74%+$11,421
D
2017-05-15
EYEGManzo Michael P.VP of EngineeringM - OptEx$0.65+7,28519,546+59%+$4,735
2017-03-13
EYEGVentech Capital II10%S - Sale$2.80-4,4191,431,8140%-$12,385-4-1-13
2017-03-07
EYEGWirostko BarbaraChief Medical OfficerA - Grant$2.83+8,700259,542+3%+$24,621-7-3-12
2017-03-06
EYEGGoldberg MortonDirS - Sale$3.00-8,9199,441-49%-$26,757-4-8-15
2017-02-28
EYEGWirostko BarbaraChief Medical OfficerA - Grant$2.59+95,900250,842+62%+$248,798-4+1-11
D
2017-02-27
EYEGGoldberg MortonDirM - OptEx$1.70+1,08318,360+6%+$1,841-4+1-11
2017-02-06
EYEGRomano SarahInterim CFOA - Grant$0.00+2,5002,500New+$0+4+4+61
2017-02-06
EYEGMann BrendaVP of Research, DevelopmentA - Grant$0.00+2,50011,751+27%+$0+1+5+66
2017-02-06
EYEGWirostko BarbaraChief Medical OfficerA - Grant$0.00+15,000154,942+11%+$0+1+5+66
2017-02-06
EYEGFrom StephenPres, CEOA - Grant$0.00+60,000199,965+43%+$0+1+5+66
2016-09-15
EYEGFrom StephenPres, CEOP - Purchase$1.49+15,000139,965+12%+$22,338+13+7+15+64
D
2016-06-30
EYEGFrom StephenPres, CEOM - OptEx$0.65+52,990124,965+74%+$34,327-5-4-20-37
2016-06-15
EYEGGoldberg MortonDirS - Sale$3.16-15,00017,277-46%-$47,361+1-9-26-51
M
2016-06-09
EYEGVentech Capital II10%S - Sale$3.04-28,6001,593,540-2%-$86,856-1+6-20-44
M
2016-06-06
EYEGVentech Capital II10%S - Sale$3.25-29,4001,622,140-2%-$95,424-1+4-21-45
D
2016-06-03
EYEGGoldberg MortonDirM - OptEx$0.65+33,77532,277-2255%+$21,8790-5-22-46
DM
2016-06-03
EYEGGoldberg MortonDirS - Sale+OE$3.31-10,93932,277-25%-$36,2030-5-22-46

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top